Detection and purification of a novel 72 kDa glycoprotein male breast tumor associated antigen

International Journal of Cancer

Volumn 105, Issue 3, 2003, Pages 377-383

  Basu, Aninda ^a   Basu, Indranil ^a   Chakraborty, Aruna ^a   Pal, Soumitro ^b   Chattopadhyay, Utpala ^a  

^a CHITTARANJAN NATIONAL CANCER INSTITUTE   (India)

^b BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

Breast tumor associated antigen; Male breast tumor; TAG 72

Indexed keywords

BREAST TUMOR ASSOCIATED ANTIGEN; GLYCOPROTEIN; MONOCLONAL ANTIBODY B.72.3; TUMOR ANTIGEN; UNCLASSIFIED DRUG;

ANTIGEN EXPRESSION; ARTICLE; BREAST DISEASE; BREAST TUMOR; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; MALE; MALE BREAST; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN PURIFICATION;

ANTIBODIES, MONOCLONAL; ANTIGENS, NEOPLASM; BLOTTING, WESTERN; BREAST NEOPLASMS, MALE; CHROMATOGRAPHY, DEAE-CELLULOSE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ENZYME-LINKED IMMUNOSORBENT ASSAY; GLYCOPROTEINS; HUMANS; MALE;

EID: 0037882108     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.11061     Document Type: Article

References (31)

1. Fox SB, Rogers S, Day CA, Underwood JC. Oestrogen receptor and epidermal growth factor receptor expression in male breast carcinoma. J Pathol 1992;166:13-8.
2. Kardas I, Seitz G, Limon J, Niezabitowski A, Rys J, Theisinger B, Welter C, Blin N. Retrospective analysis of prognostic significance of the estrogen inducible pS2 gene in male breast carcinoma. Cancer 1993;72:1652-6.
3. Blin N, Kardas I, Welter C, Rys J, Niezabitowski A, Limon J, Seitz G. Expression of the c-erbB2 proto-oncogene in male breast carcinoma: lack of prognostic significance. Oncology 1993;50:408-11.
4. Pich A, Margaria E, Chiusa L, Candelaresi G, Dal Canton O. Androgen receptor expression in male breast carcinoma: lack of clinicopathological association. Br J Cancer 1999;79:959-64.
5. Lobaccaro JM, Lumbroso S, Belon C, Galtier-Dereure F, Bringer J, Lesimple T, Namer M, Cutuli BF, Pujol H, Sultan C. Androgen receptor gene mutation in male breast cancer. Hum Mol Genet 1993;2:1799-802.
6. Vetto J, Jun SY, Paduch D, Eppich H, Shih R, Padduch D. Stages at presentation, prognostic factors, and outcome of breast cancer in males. Am J Surg 1999;177:379-83.
7. Ng RC, Roberts AN, Wilson RG, Latner AL, Turner GA. Analysis of protein extracts of human breast cancers: changes in glycoprotein content linked to the malignant phenotype. Br J Cancer 1987;55:249-54.
8. Pancino GF, Le Doussal V, Mortada MH, Berthon P, Osinaga E, Calvo F, Roseto A. Characterization and distribution in normal and tumoral human tissues of breast cancer associated antigen defined by monoclonal antibody 7B10. Cancer Res 1989;49:7078-85.
9. , Blottiere HM, Pelhate S, Aubry J, Kremer M, Thedrez P, Sai Maurel C, Douillard JY, Chatal JF. A new tumor associated antigen expressed on breast carcinomas, defined by monoclonal antibody BCA 227. Cancer Res 1991;51:1537-43.
10. Laursen I, Lykkesfeldt AE. Purification and characterization of an alpha1-antichymotrypsin like 66 kDa protein from the human breast cancer cell line MCF-7. Biochim Biophys Acta 1992;1121:119-29.
11. Duffy MJ, Shering S, Sherry F, McDermott E, O'Higgins N. CA 15-3: a prognostic marker in breast cancer. Int J Biol Markers 2000;15:330-3.
12. Ogawa Y, Ishikawa T, Ikeda K, Nakata B, Sawada T, Ogisawa K, Kato Y, Hirakawa K. Evaluation of serum KL-6, a mucin like glycoprotein, as a tumor marker for breast cancer. Clin Cancer Res 2000;6:4069-72.
13. Pal S, Sanyal U, Chattopadhyay U. Purification and characterization of a new 85 K-Da glycoprotein antigen from human breast tumor. Int J Cancer 1995;60:759-65.
14. Chattopadhyay U, Pal S. A new 85 kDa breast tumor associated antigen - a potential diagnostic and prognostic agent. J Biosci 1997;22:69-75.
15. Serra Diaz C, Vizoso F, Lamelas ML, Rodriguez JC, Gonzalez LO, Baltasar A, Medrano J. Expression and clinical significance of apolipoprotein D in male breast cancer and gynaecomastia. Br J Surg 1999;86:1190-7.
16. Chattopadhyay J, Chatterjee R, Chattopadhyay U, Chowdhury JR. Purification and partial characterization of a murine mammary tumor associated antigen. Gann 1984;75:334-41.
17. Demeter JG, Waterman NG, Verdi GD. Familial male breast carcinoma. Cancer 1990;65:2342-3.
18. Tonin PN. Genes implicated in hereditary breast cancer syndromes. Semin Surg Oncol 2000;18:281-6.
19. Stratton MR, Ford D, Neuhasen S, Seal S, Wooster R, Friedman LS, King MC, Egilsson V, Devilee P, McManus R, Daly PA, Smyth E, et al. Familial male breast cancer is not linked to the BRCA1 locus on chromosome 17q. Nat Genet 1994;7:103-7.
20. Thorlacius S, Tryggvadottir L, Olafsdottir GH, Jonasson JG, Ogmundsdottir HM, Tulinius H, Eyfjord JE. Linkage to BRCA2 region in hereditary male breast cancer. Lancet 1995;346:544-5.
21. Wick MR, Sayadi H, Ritter JH, Hill DA, Reddy VB, Gattuso P. Low stage carcinoma of the male breast: a histologic, immunohistochemical, and flow cytometric comparison with localized female breast carcinoma. Am J Clin Pathol 1999;111:59-69.
22. Munoz de Toro MM, Maffini MV, Kass L, Luque EH. Proliferative activity and steroid hormone receptor status in male breast carcinoma. J Steroid Biochem Mol Biol 1998;67:333-9.
23. Ronai Z, Sulitzeanu D. (Auto)antibodies in human breast cancer sera against antigens associated with breast cancer cells, detected by immunoblotting. J Natl Cancer Inst 1986;77:1203-9.
24. Sanchez LM, Vizoso F, Diez-Itza I, Lopez-Otin C. Identification of the major protein components in breast secretions from women with benign and malignant breast diseases. Cancer Res 1992;52:95-100.
25. Colcher D, Hand PH, Nuti M, Schlom J. A spectrum of monoclonal antibodies reactive with human mammary tumor cells. Proc Natl Acad Sci USA 1981;78:3199-203.
26. Nuti M, Teramoto YA, Mariani-Costantini R, Hand PH, Colcher D, Schlom J. A monoclonal antibody (B72.3) defines patterns of distribution of a novel tumor associated antigen in human mammary carcinoma cell populations. Int J Cancer 1982;29:539-45.
27. Stramignoni D, Bowen R, Atkinson BF, Schlom J. Differential reactivity of monoclonal antibodies with human colon adenocarcinomas and adenomas. Int J Cancer 1983;31:543-52.
28. Horan Hand P, Colcher D, Salomon D, Ridge J, Noguchi P, Schlom J. Influence of spatial configuration of carcinoma cell populations on the expression of a tumor associated glycoprotein. Cancer Res 1985;45:833-40.
29. Contegiacomo A, Alimandi M, Muraro R, Pizzi C, Calderopoli R, De Marchis L, Sgambato A, Pettinato G, Petrella G, De Filippo MR, Mariani-Costantini R. Expression of epitopes of the tumor-associated glycoprotein 72 and clinicopathological correlations in mammary carcinomas. Eur J Cancer 1994;30A:813-20.
30. Serra Diaz C, Vizoso F, Rodriguez JC, Merino AM, Gonzalez LO, Baltasar A, Perez-Vazquez MT, Medrano J. Expression of pepsinogen C in gynecomastias and male breast carcinomas. World J Surg 1999;23:439-45.
31. Balbin M, Lopez-Otin C. Hormonal regulation of the human pepsinogen C gene in breast cancer cells: identification of a cis-acting element mediating its induction by androgen, glucocorticoids, and progesterone. J Biol Chem 1996;271:15175-81.